The bulk of revenue has come from a patent on pregabalin, a synthesized organic molecule discovered by chemistry professor Richard Silverman, which ultimately was marketed as Lyrica, a drug sold by Pfizer, to combat epilepsy, neuropathic pain, and fibromyalgia.